Morrison Foerster advised CSPC Megalith Biopharmaceutical Co., Ltd. on the deal. CSPC Megalith Biopharmaceutical Co., Ltd., a subsidiary of CSPC Pharmaceutical Group Limited (Stock code: 1093.HK),...
CSPC Megalith Biopharmaceutical’s License Agreement with Corbus Pharmaceuticals
Mountaingate’s Investment in Ignite Visibility
Morrison Foerster advised Mountaingate Capital on the deal. Mountaingate Capital announced its strategic investment in Ignite Visibility, a premier digital marketing agency with proven success supporting...
CSPC Megalith Biopharmaceutical’s License Agreement with Elevation Oncology
Morrison Foerster advised CSPC Megalith Biopharmaceutical Co. on the deal. CSPC Megalith Biopharmaceutical Co., Ltd., a subsidiary of CSPC Pharmaceutical Group Limited (Stock code: 1093.HK) announced an...
Republic’s $150 Million Series B Financing
Morrison & Foerster advised Republic on the deal. Republic, a private investing platform for investors seeking high growth potential, announced its $150 million Series B Preferred Stock...
Sedgwick’s Acquisition of Managed Care Advisors
Morrison & Foerster advised Sedgwick Claim Services on the deal. Sedgwick Claim Services, a leading global provider of technology-enabled risk, benefits, and integrated business solutions, announced its...
J.P. Morgan’s Acquisition of OpenInvest
Morrison & Foerster advised OpenInvest on the deal, while Dechert advised J.P. Morgan. OpenInvest, a leading financial technology company that helps financial professionals customize and report...
LIVEKINDLY Collective’s Establishment of LIVEKINDLY Collective Africa Joint Venture
Morrison & Foerster LLP advised LIVEKINDLY Collective on the deal. LIVEKINDLY Collective, a collection of heritage and startup brands on track to become one of the...
Republic’s $36 Million Series A Financing
Morrison & Foerster LLP advised Republic on the deal. Republic, a private investing platform for investors seeking high growth potential, raised $36 million from investors including...